Investing.comCodex · 实盘不做把握 4/10
北京时间·🕒 发布 04:20:32时区推断·⟳ 抓取 04:21:00·⚡ 决策 08-04 12:41:08 +8h20m·84.4 天前
丹纳赫任命Julie Sawyer Montgomery为新CEO并确认全年指引不变
CEO交接属于董事会继任安排，生效时间为2026年10月1日。
📄 原文Investing.com↗ 原文
Danaher names Julie Sawyer Montgomery as new CEO
Dow posts first record close in nearly a month as stocks rally to kick off August WASHINGTON - Danaher Corporation (NYS…
不做 Danaher（DHR.US）
计划内CEO继任且公司确认指引不变，没有可量化新增edge，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-03 · 扩散 low · price-in 风险 low ↗
关键理由
- CEO交接属于董事会继任安排，生效时间为2026年10月1日。
- 公司明确第三季度和2026全年指引不变，未带来新增业绩上修。
主要风险
- 新CEO历史负责的诊断业务从约60亿美元增至约110亿美元，但这是履历信息，不是当前新增业绩催化。
工具调用 · 历史记录,结果未知(2 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
原文全文
展开原文 · 2,014 字
Dow posts first record close in nearly a month as stocks rally to kick off August
WASHINGTON - Danaher Corporation (NYSE:DHR) announced that its Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026, according to a press release statement.
Rainer Blair will retire on October 1 and serve as a senior advisor until March 31, 2027. Blair has served as President and CEO for the past six years.
Sawyer Montgomery joined Danaher in 2017 and most recently served as Executive Vice President with responsibility for the Diagnostics platform. During her tenure, the Diagnostics business grew from approximately $6.0 billion in revenue in 2017 to approximately $11.0 billion, while operating profit approximately tripled.
She began her career at the company at Beckman Coulter Diagnostics, leading commercial operations and R&D before becoming President in 2020. Sawyer Montgomery brings nearly 25 years of experience across healthcare, commercial operations, and R&D to the role.
"In alignment with the Board of Directors’ succession planning process, I am pleased to announce the appointment of Julie as our next Chief Executive Officer," said Steven Rales, Chairman of the Board of Directors.
Sawyer Montgomery led the recent acquisition of Masimo and the pending acquisition of StatLab, which remains subject to customary closing conditions including regulatory clearances.
"I am honored to lead Danaher into its next chapter and want to thank Rainer for his leadership," said Sawyer Montgomery.
The company announced special equity incentive awards for key leadership members and founders in conjunction with the appointment. Danaher confirmed no change to its previously communicated third quarter and full-year 2026 guidance.
Danaher operates as a life sciences and diagnostics company with approximately 60,000 associates worldwide.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
WASHINGTON - Danaher Corporation (NYSE:DHR) announced that its Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026, according to a press release statement.
Rainer Blair will retire on October 1 and serve as a senior advisor until March 31, 2027. Blair has served as President and CEO for the past six years.
Sawyer Montgomery joined Danaher in 2017 and most recently served as Executive Vice President with responsibility for the Diagnostics platform. During her tenure, the Diagnostics business grew from approximately $6.0 billion in revenue in 2017 to approximately $11.0 billion, while operating profit approximately tripled.
She began her career at the company at Beckman Coulter Diagnostics, leading commercial operations and R&D before becoming President in 2020. Sawyer Montgomery brings nearly 25 years of experience across healthcare, commercial operations, and R&D to the role.
"In alignment with the Board of Directors’ succession planning process, I am pleased to announce the appointment of Julie as our next Chief Executive Officer," said Steven Rales, Chairman of the Board of Directors.
Sawyer Montgomery led the recent acquisition of Masimo and the pending acquisition of StatLab, which remains subject to customary closing conditions including regulatory clearances.
"I am honored to lead Danaher into its next chapter and want to thank Rainer for his leadership," said Sawyer Montgomery.
The company announced special equity incentive awards for key leadership members and founders in conjunction with the appointment. Danaher confirmed no change to its previously communicated third quarter and full-year 2026 guidance.
Danaher operates as a life sciences and diagnostics company with approximately 60,000 associates worldwide.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。